Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 14/20 | 0.57 |
| ▸ | CASP6 | P55212 | 13/20 | 0.57 |
| ▸ | CASP8 | Q14790 | 13/20 | 0.57 |
| ▸ | CASP1 | P29466 | 3/20 | 0.49 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | CTSK | P43235 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3056903 | 1.00 | CASP3 (0.57) | CASP3CASP6CASP8CASP1CTSB | |
| SCHEMBL8247253 | 0.92 | CASP3 (0.67) | CASP3CASP6CASP8CASP1 | |
| SCHEMBL7745119 | 0.92 | CASP3 (0.67) | CASP3CASP6CASP8CASP1 | |
| SCHEMBL18863053 | 0.91 | CASP3 (0.55) | CASP3CASP6CASP8CASP1 | |
| SCHEMBL9415817 | 0.86 | CASP3 (0.46) | CASP3CASP6CASP8CASP1 | |
| SCHEMBL645918 | 0.84 | CASP3 (0.57) | CASP3CASP6CASP8CASP1 | |
| SCHEMBL13914069 | 0.82 | CASP3 (0.50) | CASP3CASP6CASP8CASP1CTSB | |
| SCHEMBL30472164 | 0.81 | CASP3 (0.47) | CASP3CASP6CASP8CASP1CTSB | |
| SCHEMBL13197161 | 0.80 | CASP1 (0.59) | CASP3CASP6CASP8CASP1 | |
| SCHEMBL8402109 | 0.80 | CASP1 (0.59) | CASP3CASP6CASP8CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0611375-A1 | PEPTIDES INHIBITING IL-1 BETA RELEASE | SANDOZ LTD. (CH) | 1994-08-24 | — | — | EP | disclosed |
| WO-1993009135-A1 | PEPTIDES INHIBITING IL-1 BETA RELEASE | SANDOZ LTD. (CH) | 1993-05-13 | — | — | WO | disclosed |